Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chester

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|August 15, 2002
A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancerS L Cheeseman, S P Joel, J D Chester, et al.
Oncotarget|April 9, 2016
Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapiesHanni Uusi-Kerttula, James Davies, Lynda Coughlan, et al.
Lung|October 23, 2002
Effects of granulocyte colony-stimulating factor on hyperoxia-induced lung injury in newborn pigletsL I Wolkoff, C R Levine, H C Koo, et al.
Human Gene Therapy|April 29, 2015
Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesHanni Uusi-Kerttula, Mateusz Legut, James Davies, et al.
Cancer Gene Therapy|August 13, 2011
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivoT J Harvey, I M Hennig, S D Shnyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancerJohn D Chester, Simon P Joel, Susan L Cheeseman, et al.
Viruses|June 2, 2021
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5<sub>NULL</sub>-A20James A Davies, Gareth Marlow, Hanni K Uusi-Kerttula, et al.
Cancer|May 23, 2012
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladderChristopher Blick, Peter Hall, Thinn Pwint, et al.
Cancer Gene Therapy|January 7, 2020
Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applicationsSarah L Hulin-Curtis, James A Davies, Davor Nestić, et al.
Gene Therapy|April 23, 2010
Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptorT J Harvey, D Burdon, L Steele, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|August 15, 2002
A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancerS L Cheeseman, S P Joel, J D Chester, et al.
Oncotarget|April 9, 2016
Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapiesHanni Uusi-Kerttula, James Davies, Lynda Coughlan, et al.
Lung|October 23, 2002
Effects of granulocyte colony-stimulating factor on hyperoxia-induced lung injury in newborn pigletsL I Wolkoff, C R Levine, H C Koo, et al.
Human Gene Therapy|April 29, 2015
Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer TherapiesHanni Uusi-Kerttula, Mateusz Legut, James Davies, et al.
Cancer Gene Therapy|August 13, 2011
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivoT J Harvey, I M Hennig, S D Shnyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fuorouracil-refractory metastatic colon cancerJohn D Chester, Simon P Joel, Susan L Cheeseman, et al.
Viruses|June 2, 2021
Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5<sub>NULL</sub>-A20James A Davies, Gareth Marlow, Hanni K Uusi-Kerttula, et al.
Cancer|May 23, 2012
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladderChristopher Blick, Peter Hall, Thinn Pwint, et al.
Cancer Gene Therapy|January 7, 2020
Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applicationsSarah L Hulin-Curtis, James A Davies, Davor Nestić, et al.
Gene Therapy|April 23, 2010
Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptorT J Harvey, D Burdon, L Steele, et al.
Pageof 5